期刊文献+

乳酸及APACHE II评分在脓毒症患者预后评价中的研究 被引量:7

Study of blood lactic acid dynamic monitoring and APACHE II score in evaluating septic shock
下载PDF
导出
摘要 目的研究血乳酸动态监测及急性生理学和慢性健康评估系统II(APACHEII)评分对严重脓毒症患者治疗和预后的评价作用。方法收集73例严重脓毒症患者,用早期目标指导治疗(EGDT)开始前(0h)测得的动脉血乳酸值,分为A组(2—4mmol·L-1,28例)和B组(34mmol·L-1,45例)。测定EGDT开始后6、12、24、48h及72h的血乳酸值,并计算相应的乳酸清除率,然后比较2组患者血乳酸和乳酸清除率、APACHEII评分及病死率的变化。结果A组与EGDT(0h)的血乳酸值比较,EGDT后48h及72h乳酸值有所下降,差异具有统计学意义;B组在EGDT开始后的6h乳酸值不降反升,但随后呈下降趋势,且从12h开始的乳酸值与0h比较差异有统计学意义(P〈0.05);EGDT开始后,B组在6、12、24、48及72h清除率及病死率与A组比较差异有统计学意义(P〈0.05)。结论血乳酸动态监测对严重脓毒症患者具有早期评估治疗及预后的作用,初始测定的血乳酸值越高其病死率越高。 Objective To investigate the treatment and prognosis of blood lactic acid dynamic monitoring in patients with severe sepsis. Methods According blood lactic acid levels which was monitored at the start of early goal detection treatment (EGDT), 73 pa- tients with septic shock were divided into two groups: group A (blood lactic acid: 2 -4 mmol L-1, n = 28 )and group B (blood lactic acid≥4 mmol L-1 ,n =45). The blood lactic acid was measured at 6 h, 12 h, 24 h, 48 h and 72 h and calculating the corresponding lactic acid clearance, and then compared between the two groups of blood lactic acid and lactic acid clearance rate, APACHEII score and case fatality rate changes. Results Compared to the level of blood lactic acid at Oh, group A was obviously decreased at 48 h and 72 h after EGDT, and group B was obviously decreased at 12 h, 24 h, 48 h and 72 h after EGDT, But after the start of EGDT 6 h lactic acid value was increased ( P 〈 0.05 ) ; Compared with group A, clearance of blood lactic acid in group B was decreased obviously at 6 h, 12 h, 24 h, 48 h and 72 h, and mortality of group B was higher than that in group A (P 〈 0.05). Conclusion Dynamically monitoring blood lactic acid is useful in the evaluating the treatment and prognosis of patients with septic shock. The results show the higher the blood lactic acid level, the higher mortality of patients with severe sepsis.Objective To investigate the treatment and prognosis of blood lactic acid dynamic monitoring in patients with severe sepsis. Methods According blood lactic acid levels which was monitored at the start of early goal detection treatment (EGDT), 73 pa- tients with septic shock were divided into two groups: group A (blood lactic acid: 2 -4 mmol L-1, n = 28 )and group B (blood lactic acid≥4 mmol L-1 ,n =45). The blood lactic acid was measured at 6 h, 12 h, 24 h, 48 h and 72 h and calculating the corresponding lactic acid clearance, and then compared between the two groups of blood lactic acid and lactic acid clearance rate, APACHEII score and case fatality rate changes. Results Compared to the level of blood lactic acid at Oh, group A was obviously decreased at 48 h and 72 h after EGDT, and group B was obviously decreased at 12 h, 24 h, 48 h and 72 h after EGDT, But after the start of EGDT 6 h lactic acid value was increased ( P 〈 0.05 ) ; Compared with group A, clearance of blood lactic acid in group B was decreased obviously at 6 h, 12 h, 24 h, 48 h and 72 h, and mortality of group B was higher than that in group A (P 〈 0.05). Conclusion Dynamically monitoring blood lactic acid is useful in the evaluating the treatment and prognosis of patients with septic shock. The results show the higher the blood lactic acid level, the higher mortality of patients with severe sepsis.
机构地区 宁夏人民医院ICU
出处 《宁夏医学杂志》 CAS 2014年第1期38-40,共3页 Ningxia Medical Journal
基金 宁夏自然科学基金资助项目(NZ1256) 宁夏卫生厅科研重点计划项目(2012014)
关键词 严重脓毒症 APACHE II评分 乳酸清除率 Severe sepsis Blood lactic acid lactic acid clearance
  • 相关文献

参考文献5

  • 1OBrien JM Jr,Lu B. Insurance type and sepsis -associated hospitaliza- tions and sepsis -associated mortality among US adults :a retmspective cohort study[ J]. Cfit Care,2011,15(3) :130-132.
  • 2Dellinger RP, Levy MM, Carlet JM, et al. Surviving sepsis campaign :in- ternational guidelines for management of severe sepsis and septic shock [J]. Crit Care Med,2008,36(1) :296 -327,.
  • 3王昊,吴大玮,陈晓梅,丁士芳,李琛,翟茜,尹梅.早期乳酸清除率对严重脓毒症患者的预后评估价值[J].山东大学学报(医学版),2011,49(12):85-89. 被引量:8
  • 4Okorie ON, Dellinger P. Lactate:biomarker and potential therapeu- tic target[J]. Crit Care Clin,2011,27(2) :299.
  • 5Nguyen HB, Loomba M. Early lactate clearance is associated with biomarkers of inflammation, coagulation, apoptosis, organ dysfunc- tion and mortality in severe sepsis and septic shock [ J ] Inflamma- tion,2010,7 ( 1 ) :6 - 8.

二级参考文献18

  • 1王东浩.乳酸清除率评估重度脓毒症患者预后的临床分析[J].中国急救医学,2007,27(1):15-17. 被引量:96
  • 2Angus D C,Linde-Zwirble W T,Lidicker J,et al.Epi-demiology of severe sepsis in the United States:analysisof incidence,outcome,and associated costs of care[J].Crit Care Med,2001,29(7):1303-1310.
  • 3Arnold R C,Shapiro N I,Jones A E,et al.Multi-centerstudy of early lactate clearance as a determinant of surviv-al in patients w ith presumed sepsis[J].Shock,2008,32(1):35-39.
  • 4Nguyen H B,Rivers E P,Knoblich B P,et al.Early lac-tate clearance is associated w ith improved outcome in se-vere sepsis and septic shock[J].Crit Care Med,2004,32(8):1637-1642.
  • 5Wutrich Y,Barraud D,Conrad M,et al.Early increasein arterial lactate concentration under epinephrine infusionis associated w ith a better prognosis during shock[J].Shock,2010,34(1):4-9.
  • 6Howell M D.Lactate:finally ready for prime time?[J].Crit Care Med,2009,37(10):2858-2859.
  • 7Jansen T C,van Bommel J,Bakker J.Blood lactate mo-nitoring in critically ill patients:a systematic health tech-nology assessment[J].Crit Care Med,2009,37(10):2827-2839.
  • 8Levy M M,Fink M P,Marshall J C,et al.2001SCCM/ESICM/ACCP/ATS/SIS International Sepsis DefinitionsConference[J].Crit Care Med,2003,31(4):1250-1256.
  • 9Donnino M W,Miller J,Goyal N,et al.Effective lactateclearance is associated w ith improved outcome in post-car-diac arrest patients[J].Resuscitation,2007,75(2):229-234.
  • 10Wheeler A P.Recent developments in the diagnosis andmanagement of severe sepsis[J].Chest,2007,132(6):1967-1976.

共引文献7

同被引文献53

  • 1梁波.连续性静脉-静脉血液滤过治疗严重乳酸性酸中毒临床观察[J].山东大学学报(医学版),2014,52(S02):31-31. 被引量:3
  • 2是若春,方雷,刘龙.APACHEⅡ危重病评分系统在ICU的应用[J].中华急诊医学杂志,2005,14(9):783-784. 被引量:42
  • 3Galley HF. Oxidative stress and mitochondrial dysfunction in sepsis [ J ]. Br J Anaesth,2011,107 ( 1 ) :57-64.
  • 4Esper AM, Moss M, Lewis CA, et al. The role of infection and comorbidity:Factors that influence disparities in sepsis[ J]. Crit Care Med , 2006,34 : 2576-2582 .
  • 5UtzolinoS, Hopt UT, Kaffamik M. Postoperative sepsis : diagnosis, specialfeatures, management [ J ]. Zentralbl Chir, 2010, 135 ( 3 ) : 240 -248.
  • 6Palmiere C, Augsburger M. Markers for sepsis diagnosis in the forensic setting : state of the art. [ J]. Croat Med ,2014,55 ( 2 ) : 103-114.
  • 7Guirgis FW, Khadpe JD, Kuntz GM, et al. Jones AE. Persistent organ dysfunction after severe sepsis : a systematic review [ J ]. J Crit Care, 2014 ,29 (3) :320-326.
  • 8Axtelle T, Pribble J. An overview of clinical studies in healthy subjects and patients with severe sepsis with IC14, a CDl4-specific chimeric monoclonal antibody [ J ]. J Endotoxin Res, 2003,9 ( 6 ) : 385-389.
  • 9Kleinpell B. Advances in treating patients with severe sepsis[ J]. CritcareNurse, 2003,23 ( 3 ) : 16 -29.
  • 10Bolliger D, Seeberger MD, Tanaka KA. Principles and practice of thromboelastography in clinical coagulation management and transfusion practice[ J]. Transfus Med Rev ,2012,26 : 1-13.

引证文献7

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部